Ronald G. Gelbman, Director at HAEMONETICS CORP (HAE), sold 11,310 shares at $40.07 ($453K) on 2012-12-13, disclosed to the SEC on 2012-12-17.
Open-market sale of $453k HAE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.07 | 3,390 | $136K | 30.0% |
| 2 | $40.07 | 7,920 | $317K | 70.0% |
| Total | $40.07 avg | 11,310 | $453K | 100% |
| Filing → |
| HAE | SELL | 2019-02-19 | $1.4M | — | Filing → |
| HAE | SELL | 2018-12-18 | $892K | — | Filing → |
| HAE | SELL | 2017-11-17 | $331K | — | Filing → |